We are live on
!
Find out more
CM
Castleark Management Portfolio holdings
AUM
$3.02B
1-Year Est. Return
53.92%
This Fund
S&P 500
This Quarter
Est. Return
+9.86%
1 Year Est. Return
+53.92%
3 Year Est. Return
+208.37%
5 Year Est. Return
+342.22%
10 Year Est. Return
+3,246.09%
AUM
$4.15B
AUM Growth
+$266M
(+6.8%)
Cap. Flow
+$9.96M
Cap. Flow
% of AUM
0.24%
Top 10 Holdings %
Top 10 Hldgs %
18.91%
Holding
413
New
73
Increased
124
Reduced
81
Closed
59
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Aptiv
APTV
|
+$80M |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$76.5M |
| 3 |
Medtronic
MDT
|
+$62.6M |
| 4 |
iShares MSCI Japan ETF
EWJ
|
+$51.4M |
| 5 |
Oracle
ORCL
|
+$43.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$53.7M |
| 2 |
Macy's
M
|
+$48.7M |
| 3 |
Stratasys
SSYS
|
+$38.1M |
| 4 |
UnitedHealth
UNH
|
+$36.6M |
| 5 |
Starbucks
SBUX
|
+$32.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.39% |
| 2 | Consumer Discretionary | 16.68% |
| 3 | Technology | 15.87% |
| 4 | Energy | 10.53% |
| 5 | Industrials | 8.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Wabtec
WAB
$49.3B
| $39.8M | 0.96% |
418,820
-109,550
| -21% | -$9.88M |
|
|
HZNP
27
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $39.5M | 0.95% |
1,519,050
+917,550
| +153% | +$16.8M |
|
|
28
Starbucks
SBUX
$119B
| $39.4M | 0.95% |
831,360
-729,580
| -47% | -$32.8M |
|
29
Blackrock
BLK
$167B
| $37M | 0.89% |
101,230
-75,800
| -43% | -$27.5M |
|
30
Middleby
MIDD
$6.01B
| $35.5M | 0.86% |
345,403
-91,623
| -21% | -$9.31M |
|
31
Illumina
ILMN
$29.5B
| $34.7M | 0.84% |
192,002
-368
| -0.2% | -$69.3K |
|
32
BorgWarner
BWA
$12.8B
| $33.4M | 0.81% |
627,526
-362,952
| -37% | -$18.5M |
|
33
Merck
MRK
$322B
| $32.4M | 0.78% |
590,496
+279,785
| +90% | +$15.8M |
|
34
ConocoPhillips
COP
$144B
| $32.3M | 0.78% |
519,162
+46,022
| +10% | +$2.98M |
|
35
Tapestry
TPR
$30.3B
| $30.5M | 0.73% |
735,425
+733,925
| +48,928% | +$29.2M |
|
|
36
UnitedHealth
UNH
$382B
| $29.1M | 0.7% |
245,870
-329,870
| -57% | -$36.6M |
|
|
SWN
37
DELISTED
Southwestern Energy Company
SWN
| $27.9M | 0.67% |
1,202,210
-278,647
| -19% | -$6.92M |
|
|
38
Macy's
M
$6.51B
| $27.5M | 0.66% |
423,480
-757,300
| -64% | -$48.7M |
|
|
MDVN
39
DELISTED
MEDIVATION, INC.
MDVN
| $27.4M | 0.66% |
424,440
-137,310
| -24% | -$7.87M |
|
40
CBRE Group
CBRE
$43.3B
| $25.8M | 0.62% |
666,712
-467,530
| -41% | -$16.1M |
|
41
C.H. Robinson
CHRW
$20.5B
| $23.7M | 0.57% |
323,412
-180,338
| -36% | -$13.2M |
|
42
Helen of Troy
HELE
$656M
| $23.4M | 0.57% |
+287,668
| New | +$21.9M |
|
43
Hain Celestial
HAIN
$44.6M
| $23.4M | 0.56% |
365,718
-169,466
| -32% | -$10M |
|
44
iShares MSCI Emerging Markets ETF
EEM
$27.5B
| $23.2M | 0.56% |
577,900
| – | – |
|
45
Salesforce
CRM
$154B
| $23.1M | 0.56% |
+345,620
| New | +$21.4M |
|
46
Alphabet (Google) Class C
GOOG
$4.11T
| $22.8M | 0.55% |
835,688
-606,661
| -42% | -$16.3M |
|
47
PACCAR
PCAR
$70.5B
| $22.1M | 0.53% |
525,765
-698,679
| -57% | -$29.7M |
|
48
Acadia Healthcare
ACHC
$2.52B
| $20.7M | 0.5% |
289,254
+35,679
| +14% | +$2.29M |
|
|
VRNT
49
DELISTED
Verint Systems
VRNT
| $20.5M | 0.49% |
649,987
-13,495
| -2% | -$397K |
|
50
Edwards Lifesciences
EW
$49.4B
| $20M | 0.48% |
+840,480
| New | +$18.9M |
|
Similar funds
MCM
JIC
CFM
SM
TAM
KIA
BGDI
Castleark Management's Q1 2015 Portfolio in Review
As of Q1 2015, Castleark Management held 413 positions worth $4.15B, up 6.8% from $3.88B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Castleark Management's Q1 2015 filing shows 73 new, 124 increased, 81 reduced and 59 closed positions. Its largest new stake was Aptiv: 1,064,780 shares worth $84.9M. The largest sale was State Street Financial Select Sector SPDR ETF, an estimated $53.7M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Technology.
- Castleark Management's largest Q1 2015 buy was Aptiv: 1,064,780 shares worth $84.9M.
- Castleark Management added most to Medtronic in Q1 2015, an estimated $62.6M increase.
- Castleark Management's biggest Q1 2015 reduction was State Street Financial Select Sector SPDR ETF, cutting an estimated $53.7M.
- Castleark Management fully exited Stratasys in Q1 2015, selling an estimated $38.1M.
- Castleark Management's ten largest holdings make up 19% of its $4.15B portfolio in Q1 2015.
- Castleark Management opened 73 new positions and closed 59 in Q1 2015.
- Castleark Management's portfolio value rose 6.8% quarter-over-quarter to $4.15B.
Based on Castleark Management's 13F filing for Q1 2015, filed 15 May 2015.